Anti-depressant medication use and C-reactive protein: Results from two population-based studies
- 31 December 2010
- journal article
- research article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 25 (1), 168-173
- https://doi.org/10.1016/j.bbi.2010.09.013
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- National Patterns in Antidepressant Medication TreatmentArchives of General Psychiatry, 2009
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart DiseaseJama-Journal Of The American Medical Association, 2009
- Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: Effects on proinflammatory cytokines and acute phase protein levelsInternational Journal of Cardiology, 2009
- Long-Term Use of Antidepressants for Depressive Disorders and the Risk of Diabetes MellitusAmerican Journal of Psychiatry, 2009
- Depression Is Associated With Decreased Blood Pressure, but Antidepressant Use Increases the Risk for HypertensionHypertension, 2009
- Inflammatory markers in depressionCurrent Opinion in Psychiatry, 2009
- Antidepressant Use, Depression, and Survival in Patients With Heart FailureJAMA Internal Medicine, 2008
- Genetically Elevated C-Reactive Protein and Ischemic Vascular DiseaseThe New England Journal of Medicine, 2008
- A Self-Fulfilling ProphecyCirculation, 2002
- Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents∗∗Access the “Journal Club” discussion of this paper at http://www.elsevier.com/locate/ajmselect/American Journal Of Medicine, 2000